<qa>  What is the purpose of this study?The purpose of this study is to evaluate the activity and tolerability of pazopanib in subjects with advanced andor metastatic soft tissue sarcoma who have relapsed following standard therapies or for whom no standard therapy exists and to characterize the pharmacokinetics of pazopanib in this subject population. 